Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured ...

FDA Recall #D-1074-2019 — Class II — March 29, 2019

Recall #D-1074-2019 Date: March 29, 2019 Classification: Class II Status: Terminated

Product Description

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

Reason for Recall

Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.

Recalling Firm

Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

12,960 bottles

Distribution

Nationwide in the USA.

Code Information

Lot #: PA217060A, Exp 05/2020

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated